Condition: Obesity · Overweight · Diabetes Mellitus, Type 2 · Sponsor: Eli Lilly and Company
The purpose of this study is to investigate weight reduction with macupatide and eloralintide, alone or in combination, in adult participants with obesity or overweight and with type 2 diabetes. Participation in the study will last about 48 weeks.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC | Gilbert, Arizona, United States | Recruiting |
| Synexus Clinical Research US, Inc. | Phoenix, Arizona, United States | Recruiting |
| Pima Heart | Tucson, Arizona, United States | Recruiting |
| Precision Clinical Research | Sunrise, Florida, United States | Recruiting |
| SKY Clinical Research Network Group-Brown | Atlanta, Georgia, United States | Recruiting |
| Teak Research Consults | Lawrenceville, Georgia, United States | Recruiting |
| AGILE Clinical Research Trials, LLC | Sandy Springs, Georgia, United States | Recruiting |
| Pivotal Research Solutions | Stonecrest, Georgia, United States | Recruiting |
| Rophe Adult and Pediatric Medicine/SKYCRNG | Union City, Georgia, United States | Recruiting |
| Vector Clinical Trials | Las Vegas, Nevada, United States | Recruiting |
| Premier Research | Trenton, New Jersey, United States | Recruiting |
| PriMED Clinical Research | Dayton, Ohio, United States | Recruiting |
+ 30 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07215559